Terazawa, Tetsuji
Kato, Takeshi
Goto, Masahiro
Sakai, Daisuke
Kurokawa, Yukinori
Shimokawa, Toshio
Matsubara, Yoshihiro
Satoh, Taroh
Funding for this research was provided by:
Takeda Pharmaceutical Company Limited
Article History
Received: 15 December 2017
Accepted: 11 June 2019
First Online: 25 June 2019
Ethics approval and consent to participate
: Approval was obtained by the ethical committee of Osaka Medical College approved this study on November 7, 2016. Trial registration number was UMIN000024528 on December 1, 2016. A signed informed consent is obtained from all patients included in the trial. It was registered prospectively (the day of enrollment of the first participant was February 9, 2016).
: Not applicable.
: The present study is supported by OGSG and funded by Takeda Pharmaceutical Company Limited. This study protocol has not undergone peer-review by the funding body.The authors declare that they have no competing interests.